胰岛素诱导低血糖症的狗体外胰岛素瘤:一个病例报告
Jiwon Kim1, Insun Hwang2, Danbee Kwon2
1Department of Veterinary Medical Imaging, College of Veterinary Medicine, Jeonbuk National University, Iksan 54596, Korea.
Journal of veterinary science
|June 4, 2023
概括
异位胰岛素瘤是犬类低血糖症的罕见原因,被确定为Shih Tzu的中肠结节. 通过手术切除这种小岛细胞癌,可解决复发性低血糖症.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 狗内分泌学 狗内分泌学
- 手术瘤学手术瘤学
背景情况:
- 狗的反复性低血糖症可能是由各种因素引起的,包括胰岛素瘤.
- 宫外胰腺瘤很少见,但可能会带来诊断挑战.
研究的目的:
- 报告一种罕见的异胎性胰岛素瘤病例,导致狗的低血糖.
- 为突出诊断和手术考虑不寻常的瘤位置.
主要方法:
- 一个7岁的石子的临床表现,患有复发性低血糖症.
- 诊断成像 (超声波,CT) 以定位高胰岛素的来源.
- 手术探索,结节切除,以及他的病理学检查.
主要成果:
- 一个与胰腺分离的中腔结节被识别并切除.
- 组织病理学证实了结节是小岛细胞癌 (胰岛素瘤).
- 手术后实现了低血糖症的缓解.
结论:
- 宫外胰岛素瘤虽然很少见,但在犬类低血糖病例中必须考虑.
- 外宫瘤的手术切除可以治愈.
- 诊断成像和手术探索对于识别非胰腺胰岛素产生瘤至关重要.
相关概念视频
Hypoglycemia and Glucagon
306
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
306
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Insulin: Dosing Regimen and Adverse Effects
216
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
216
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Insulin Secretory Vesicles
5.0K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K
Insulin: Biosynthesis, Chemistry, and Preparation
443
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
443


